InvestorsHub Logo
Followers 1607
Posts 120300
Boards Moderated 3
Alias Born 07/09/2003

Re: RIGATONI post# 379122

Tuesday, 02/20/2024 11:38:06 AM

Tuesday, February 20, 2024 11:38:06 AM

Post# of 380864
Intellectual Property

There's a ton going on here under the hood>>>

The table below sets forth a summary of our intellectual property rights.


Patents:
Country: Nigeria

Patent Number: NG/PT/PCT/2022/6494

Issue Date: February 20, 2023

Application Number: NG/PT/PCT/2022/6494

Filing Date: April 10, 2021


Patent Applications:
Organicell™ has two U.S. Patent Applications on file for its Organicell™ line of products and the proprietary techniques used for processing perinatal fluid.
U.S. Patent Application No. 17/226,587
Titled: COMPOSITIONS COMPRISING NANOPARTICLES, METHOD OF MAKING AND USES THEREOF
Filed: April 9, 2021
Inventor: Maria Ines Mitrani
Applicant: Organicell Regenerative Medicine, Inc.

Assignment: MARIA INES MITRANI (Assignor), ORGANICELL REGENERATIVE MEDICINE, INC. (Assignee)
Recorded: April 9, 2021
Real/Frame: 055878 / 0801 & 055878 / 0900

U.S. Patent Application No. 17/990,522 (Continuation of 17/226,587)
Titled: COMPOSITIONS COMPRISING NANOPARTICLES, METHOD OF MAKING AND USES THEREOF
Filed: November 18, 2022
Inventor: Maria Ines Mitrani
Applicant: Organicell Regenerative Medicine, Inc.

Assignment: MARIA INES MITRANI (Assignor), ORGANICELL REGENERATIVE MEDICINE, INC. (Assignee)
Recorded: April 9, 2021
Real/Frame: 055878 / 0801 & 055878 / 0900

Organicell™ has twenty-five Ex-US Patent Applications on file for its Organicell™ line of products and the proprietary techniques used for processing perinatal fluid. These Applications are national stage entries of:
International Patent Application No. PCT/IB2021/052982
Titled: COMPOSITIONS COMPRISING NANOPARTICLES, METHOD OF MAKING AND USES THEREOF
Filed: April 10, 2021
Inventor: Maria Ines Mitrani
Applicant: Organicell Regenerative Medicine, Inc.

Assignment: MARIA INES MITRANI (Assignor), ORGANICELL REGENERATIVE MEDICINE, INC. (Assignee)

Country: Australia
Application Number: 2021253889
Filing Date: April 10, 2021

10

Country: Brazil
Application Number: BR112022020441-8
Filing Date: April 10, 2021

Country: Canada
Application Number: 3179925
Filing Date: April 10, 2021

Country: China
Application Number: 202180041860.8
Filing Date: April 10, 2021

Country: Colombia
Application Number: NC2022/0015966
Filing Date: April 10, 2021

Country: Costa Rica
Application Number: 2022-570
Filing Date: April 10, 2021

Country: Ecuador
Application Number: SENADI-2022-86300
Filing Date: April 10, 2021

Country: Europe
Application Number: 21784900.9
Filing Date: April 10, 2021

Country: Indonesia
Application Number: P00202212337
Filing Date: April 10, 2021

Country: Israel
Application Number: 297195
Filing Date: April 10, 2021

Country: India
Application Number: 202217062549
Filing Date: April 10, 2021

Country: Japan
Application Number: 2022-562119
Filing Date: April 10, 2021

Country: Republic of Korea
Application Number: 10-2022-7039360
Filing Date: April 10, 2021

Country: Saint Lucia
Application Number: Not available
Filing Date: April 10, 2021

11

Country: Mexico
Application Number: MX/a/2022/012692
Filing Date: April 10, 2021

Country: Malaysia
Application Number: PI2022005623
Filing Date: April 10, 2021

Country: New Zealand
Application Number: 793562
Filing Date: April 10, 2021

Country: Panama
Application Number: 94165-01
Filing Date: April 10, 2021

Country: Philippines
Application Number: 1-2022-552738
Filing Date: April 10, 2021

Country: Qatar
Application Number: QA/202210/0000698
Filing Date: April 10, 2021

Country: Saudi Arabia
Application Number: 522440872
Filing Date: April 10, 2021

Country: Singapore
Application Number: 11202253965C
Filing Date: April 10, 2021

Country: Thailand
Application Number: 2201006618
Filing Date: April 10, 2021

Country: Vietnam
Application Number: 1-2022-06884
Filing Date: April 10, 2021

Country: South Africa
Application Number: 2022/11630
Filing Date: April 10, 2021

Country: Jordan
Application Number: PCT/JO/2022/259
Filing Date: April 10, 2021


Country: United Arab Emirates
Application Number: P6002103/2022
Filing Date: April 10, 2021

12

Organicell™ has a U.S. Patent Application on file for its Organicell™ PPX product and the proprietary techniques used in the administration of blood-derived exosomes to treat pain.
U.S. Patent Application No. 18/063,227
Titled: COMPOSITIONS AND METHODS FOR TREATING PAIN WITH EXTRACELLULAR VESICLES
Filed: December 8, 2022
Inventors: Maria Ines Mitrani, Michael Bellio, and Albert Mitrani
Applicant: Organicell Regenerative Medicine, Inc.

Organicell™ has an International Patent Application on file for its Organicell™ PPX product and the proprietary techniques used in the administration of blood-derived exosomes to treat pain
International Patent Application No. PCT/US2022/081146
Titled: COMPOSITIONS AND METHODS FOR TREATING PAIN WITH EXTRACELLULAR VESICLES
Filed: December 8, 2022
Inventors: Maria Ines Mitrani, Michael Bellio, and Albert Mitrani
Applicant: Organicell Regenerative Medicine, Inc.


Trademarks: Word Mark: ZOFIN
Goods/Services: Biologically derived products developed from perinatal tissue material in the nature of cultured biological tissue and non-cultured biological tissue, for aesthetic purposes, other than for medical or veterinary purposes (IC 001); Biologically derived products developed from perinatal tissue material for medical and medical regenerative purposes, namely, biological tissue grafts, implants comprising living tissue, surgical implants comprising living tissue, and biological implants for cushioning tissues and supporting tissue repair and homeostasis (IC 005)
Serial Number: 90050511
Filing Date: July 13, 2020
Owner: Organicell Regenerative Medicine, Inc.
Status: Notice of allowance issued May 18, 2021; Non-Final Office Action re specimen issued July 5, 2023; Response to Non-Final Office Action filed October 5, 2023; Awaiting further examination.

Word Mark: ORGANICELL
Goods/Services: Biologically derived products developed from perinatal tissue material in the nature of cultured biological tissue and non-cultured biological tissue, for aesthetic purposes, other than for medical or veterinary purposes (IC 001); Biologically derived products developed from perinatal tissue material for medical and medical regenerative purposes, namely, biological tissue grafts, implants comprising living tissue, surgical implants comprising living tissue, and biological implants for cushioning tissues and supporting tissue repair and homeostasis (IC 005)
Serial Number: 88903989
Filing Date: May 6, 2020
Owner: Organicell Regenerative Medicine, Inc.

13

Word Mark: ORGANICELL
Goods/Services: Non-medicated anti-aging serum; non-medicated skin serums; all of the aforementioned goods are made in whole or in substantial part of organic ingredients (IC 003)
Serial Number: 87311045
Filing Date: January 23, 2017
Status: Registered

Owner: Organicell Regenerative Medicine, Inc.

Registration Number: 5289671
Registration Date: September 19, 2017

Word Mark: PATIENT PURE X - PPX
Goods/Services: plasma extracts for medical use, namely, plasma extract containing purified and concentrated exosomes derived from whole human blood (IC 005)
Serial Number: 88771931
Filing Date: January 24, 2020
Owner: Organicell Regenerative Medicine, Inc.

Word Mark: PATIENT PURE X - PPX
Goods/Services: plasma processing services for others, namely, extracting purified and concentrated exosomes based on whole blood harvested from patients for use by hospitals, clinics, or other organizations or persons involved in delivering healthcare services to patients (IC 040)
Serial Number: 88771934
Filing Date: January 24, 2020

Word Mark: ZEO SCIENTIFIX


Goods/Services: manufacturing services, biotechnological products and services, research services, laboratory services, biologics therapeutics, and biologics diagnostics

Serial Number: 98307890

Filing Date: December 11, 2023

Owner: Organicell Regenerative Medicine, Inc.

Status: Awaiting examination

Composite Mark: ZEO SCIENTIFIX (Stylized/Design)

Goods/Services: manufacturing services, biotechnological products and services, research services, laboratory services, biologics therapeutics, and biologics diagnostics

Serial Number: 98307906

Filing Date: December 11, 2023

Owner: Organicell Regenerative Medicine, Inc.

Status: Awaiting examination

14
Word Mark: HEALTHY X

Goods/Services: manufacturing services in the field of biotechnological products, biotechnological products, development of products for others in the field of biotechnology, biotechnology research, scientific laboratory services, therapeutic services featuring biologics, biologics diagnostic testing

Serial Number: 98327846

Filing Date: December 22, 2023

Owner: Organicell Regenerative Medicine, Inc.

Status: Awaiting examination



Word Mark: PPX

Goods/Services: biotechnological products, namely, blood-derived biologics

Serial Number: 98341677

Filing Date: January 4, 2024

Owner: Organicell Regenerative Medicine, Inc.

Status: Awaiting examination

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.